1. Natarajan A, Beena P, Devnikar AV, Mali S. A systemic review on tuberculosis. Indian J Tuberc 2020;67:295-311. [DOI:10.1016/j.ijtb.2020.02.005]

2. World Health Organization. Global tuberculosis report 2024. Geneva: WHO; 2025. [Available from: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024]

3. Park M, Satta G, Kon OM. An update on multidrug-resistant tuberculosis. Clin Med 2019;19:135-9. [DOI:10.7861/clinmedicine.19-2-135]

4. Ferdosnejad K, Sholeh M, Abdolhamidi R, Soroush E, Siadat SD, Tarashi S. The occurrence rate of Haarlem and Beijing genotypes among Middle Eastern isolates of multi drug resistant Mycobacterium tuberculosis: A systematic review and meta-analysis. Respir Investig 2024;62:296-304. [DOI:10.1016/j.resinv.2024.01.010]

5. Bialvaei AZ, Asgharzadeh M, Aghazadeh M, Nourazarian M, Kafil HS. Challenges of tuberculosis in Iran. Jundishapur J Microbiol 2017;10:e37866. [DOI:10.5812/jjm.37866]

6. Torkaman MRA, Nasiri MJ, FaRnia P, Shahhosseiny MH, Mozafari M, Velayati AA. Estimation of recent transmission of Mycobacterium tuberculosis strains among Iranian and Afghan immigrants: A cluster-based study. J Clin Diagn Res 2014;8:DC05-8.

7. Ferdosnejad K, Zamani MS, Soroush E, Fateh A, Siadat SD, Tarashi S. Tuberculosis and lung cancer: metabolic pathways play a key role. Nucleosides Nucleotides Nucleic Acids 2024:1-20. [DOI:10.1080/15257770.2024.2308522]

8. Iran MoHo. Ministry of Health of Iran. National Center for Tuberculosis and Leprosy Control web site 2017. Available from: http://tb-lep.behdasht.gov.ir/TB_HIV_Situation_in_Iran.aspx.

9. Kim JK, Silwal P, Jo E-K. Host-pathogen dialogues in autophagy, apoptosis, and necrosis during mycobacterial infection. Immune Netw 2020;20:e37. [DOI:10.4110/in.2020.20.e37]

10. Tarashi S, Omrani MD, Moshiri A, Fateh A, Siadat SD, Fuso A. The correlation of microbiota and host epigenome in tuberculosis. In: Rezaei N, ed. Tuberculosis. Integrated Studies for a Complex Disease. SpringerLink; 2023. p. 977-1002. [DOI:10.1007/978-3-031-15955-8_47]

11. Ekert PG, Vaux DL. Apoptosis and the immune system. Br Med Bull 1997;53:591-603. [DOI:10.1093/oxfordjournals.bmb.a011632]

12. Opferman JT, Korsmeyer SJ. Apoptosis in the development and maintenance of the immune system. Nat Immunol 2003;4:410-5. [DOI:10.1038/ni0503-410]

13. Walker N, Harmon B, Gobe G, Kerr J. Patterns of cell death. Methods Achiev Exp Pathol 1988;13:18-54.

14. Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003;22:8590-607. [DOI:10.1038/sj.onc.1207102]

15. MacFarlane M, Williams AC. Apoptosis and disease: a life or death decision. EMBO Rep 2004;5:674-8. [DOI:10.1038/sj.embor.7400191]

16. Berghe TV, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014;15:135-47. [DOI:10.1038/nrm3737]

17. Rello S, Stockert J, Moreno V, Gamez A, Pacheco M, Juarranz A, et al. Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 2005;10:201-8. [DOI:10.1007/s10495-005-6075-6]

18. Flores‐Romero H, Ros U, Garcia‐Saez AJ. Pore formation in regulated cell death. EMBO J 2020;39:e105753. [DOI:10.15252/embj.2020105753]

19. Danelishvili L, McGarvey J, Li Yj, Bermudez LE. Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol 2003;5:649-60. [DOI:10.1046/j.1462-5822.2003.00312.x]

20. Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997;65:298-304. [DOI:10.1128/iai.65.1.298-304.1997]

21. Mvubu NE, Pillay B, McKinnon LR, Pillay M. Mycobacterium tuberculosis strains induce strain-specific cytokine and chemokine response in pulmonary epithelial cells. Cytokine 2018;104:53-64. [DOI:10.1016/j.cyto.2017.09.027]

22. Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol 2000;164:2016-20. [DOI:10.4049/jimmunol.164.4.2016]

23. Zhan L, Wang J, Wang L, Qin C. The correlation of drug resistance and virulence in Mycobacterium tuberculosis. Biosafety and Health 2020;2:18-24. [DOI:10.1016/j.bsheal.2020.02.004]

24. Rezaei N, Hosseini N-S, Saghazadeh A, Fateh A, Duse A, Ahmad A, et al. Tuberculosis: integrated studies for a complex disease 2050. SpringerLink; 2023. P.1063-98. [DOI:10.1007/978-3-031-15955-8_1]

25. Schroeder M, Brooks BD, Brooks AE. The complex relationship between virulence and antibiotic resistance. Genes 2017;8:39. [DOI:10.3390/genes8010039]

26. Lam A, Prabhu R, Gross CM, Riesenberg LA, Singh V, Aggarwal S. Role of apoptosis and autophagy in tuberculosis. Am J Physiol Lung Cell Mol Physiol 2017;313:L218-L29. [DOI:10.1152/ajplung.00162.2017]

27. van Klingeren B, Dessens-Kroon M, van der Laan T, Kremer K, van Soolingen D. Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method. J Clin Microbiol 2007;45:2662-8. [DOI:10.1128/JCM.00244-07]

28. Woods GL, Brown-Elliott BA, Conville PS, Desmond EP, Hall GS, Lin G, et al. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes [Internet]. 2nd ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2011 Mar. Report No.: M24-A2.

29. Association NT. Diagnostic standards and classification of tuberculosis. New York: National tuberculosis association; 1940.

30. Vaziri F, Kohl TA, Ghajavand H, Kargarpour Kamakoli M, Merker M, Hadifar S, et al. Genetic diversity of multi-and extensively drug-resistant Mycobacterium tuberculosis isolates in the capital of Iran, revealed by whole-genome sequencing. J Clin Microbiol 2019;57: e01477-18. [DOI:10.1128/JCM.01477-18]

31. Caceres N, Vilaplana C, Prats C, Marzo E, Llopis I, Valls J, et al. Evolution and role of corded cell aggregation in Mycobacterium tuberculosis cultures. Tuberculosis 2013;93:690-8. [DOI:10.1016/j.tube.2013.08.003]

32. Sequeira PC, Senaratne RH, Riley LW. Inhibition of toll-like receptor 2 (TLR-2)-mediated response in human alveolar epithelial cells by mycolic acids and Mycobacterium tuberculosis mce1 operon mutant. Pathog Dis 2014;70:132-40. [DOI:10.1111/2049-632X.12110]

33. Louis KS, Siegel AC. Cell viability analysis using trypan blue: manual and automated methods. Methods Mol Biol 2011;740:7-12. [DOI:10.1007/978-1-61779-108-6_2]

34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 2001;25:402-8. [DOI:10.1006/meth.2001.1262]

35. Danial NN. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 2007;13:7254-63. [DOI:10.1158/1078-0432.CCR-07-1598]

36. Schmidt E, Tuder R. Role of apoptosis in amplifying inflammatory responses in lung diseases. J Cell Death 2010;3:41-53. [DOI:10.4137/JCD.S5375]

37. Srinivasan L, Ahlbrand S, Briken V. Interaction of Mycobacterium tuberculosis with host cell death pathways. Cold Spring Harb Perspect Med 2014;4:a022459. [DOI:10.1101/cshperspect.a022459]

38. Abdalla AE, Ejaz H, Mahjoob MO, Alameen AAM, Abosalif KOA, Elamir MYM, Mousa MA. Intelligent mechanisms of macrophage apoptosis subversion by mycobacterium. Pathogens 2020;9:218. [DOI:10.3390/pathogens9030218]

39. Tarashi S, Fateh A, Mirsaeidi M, Siadat SD, Vaziri F. Mixed infections in tuberculosis: the missing part in a puzzle. Tuberculosis 2017;107:168-74. [DOI:10.1016/j.tube.2017.09.004]

40. Tarashi S, Badi SA, Moshiri A, Nasehi M, Fateh A, Vaziri F, et al. The human microbiota in pulmonary tuberculosis: Not so innocent bystanders. Tuberculosis 2018;113:215-21. [DOI:10.1016/j.tube.2018.10.010]

41. Tong J, Meng L, Bei C, Liu Q, Wang M, Yang T, et al. Modern Beijing sublineage of Mycobacterium tuberculosis shift macrophage into a hyperinflammatory status. Emerg Microbes Infect 2022;11:715-24. [DOI:10.1080/22221751.2022.2037395]

42. Porcelli SA, Jacobs Jr WR. Tuberculosis: unsealing the apoptotic envelope. Nat Immunol 2008;9:1101-2. [DOI:10.1038/ni1008-1101]

43. Behar SM, Divangahi M, Remold HG. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol 2010;8:668-74. [DOI:10.1038/nrmicro2387]

44. Lin Y, Zhang M, Barnes PF. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun 1998;66:1121-6. [DOI:10.1128/IAI.66.3.1121-1126.1998]

45. Guiedem E, Pefura-Yone EW, Ikomey GM, Nkenfou CN, Mesembe M, Yivala MM, et al. Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease. BMC Immunol 2020;21:1-11. [DOI:10.1186/s12865-020-00381-w]

46. Alemán M, Garcia A, Saab MA, De La Barrera SS, Finiasz M, Abbate E, et al. Mycobacterium tuberculosis-induced activation accelerates apoptosis in peripheral blood neutrophils from patients with active tuberculosis. Am J Respir Cell Mol Biol 2002;27:583-92. [DOI:10.1165/rcmb.2002-0038OC]

47. Zhang W, Zhu T, Chen L, Luo W, Chao J. MCP-1 mediates ischemia-reperfusion-induced cardiomyocyte apoptosis via MCPIP1 and CaSR. Am J Physiol Heart Circ Physiol 2020;318:H59-H71. [DOI:10.1152/ajpheart.00308.2019]

48. Ooppachai C, Limtrakul P, Yodkeeree S. Dicentrine potentiates TNF-α-induced apoptosis and suppresses invasion of A549 lung adenocarcinoma cells via modulation of NF-κB and AP-1 activation. Molecules 2019;24:4100. [DOI:10.3390/molecules24224100]

49. Wen L-P, Madani K, Fahrni JA, Duncan SR, Rosen GD. Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-γ and Fas. Am J Physiol 1997;273:L921-L9. [DOI:10.1152/ajplung.1997.273.5.L921]

50. Bailey DP, Kashyap M, Bouton LA, Murray PJ, Ryan JJ. Interleukin-10 induces apoptosis in developing mast cells and macrophages. J Leukoc Biol 2006;80:581-9. [DOI:10.1189/jlb.0405201]

51. San LL, Aye KS, Oo NAT, Shwe MM, Fukushima Y, Gordon SV, et al. Insight into multidrug-resistant Beijing genotype Mycobacterium tuberculosis isolates in Myanmar. Int J Infect Dis 2018;76:109-19. [DOI:10.1016/j.ijid.2018.06.009]

52. Nguyen L. Antibiotic resistance mechanisms in M. tuberculosis: an update. Arch Toxicol 2016;90:1585-604. [DOI:10.1007/s00204-016-1727-6]

53. Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 2010;8:260-71. [DOI:10.1038/nrmicro2319]